This was the stock's second consecutive day of losses.

JPMD will offer clients round-the-clock settlement as well as the ability to pay interest to holders. It is a so-called ...

Regeneron Pharmaceuticals was outbid in its effort to buy 23andMe by a nonprofit led by the bankrupt genetics testing company’s co-founder. California-based TTAM Research Institute, led by Anne ...

Regeneron Pharmaceuticals (NASDAQ:REGN) has reportedly declined to submit a higher bid for 23andMe (OTC:MEHCQ) after a ...

JPMorgan has filed for a second trademark, “JPMD.” The U.S. Senate’s advancement of the bipartisan GENIUS Act has offered ...